申请人:TAISHO PHARMACEUTICAL CO. LTD
公开号:EP0695754A1
公开(公告)日:1996-02-07
An indolo[2-3-b]quinoxaline derivative represented by general formula (I) (wherein one of R¹ and R² represents hydrogen and the other represents -CH₂NHCCH₃(CH₂OH)₂, etc.; and R³ represents hydrogen, methyl, etc.) or a pharmaceutically acceptable salt thereof has an antitumor effect and therefore is useful as a drug.
通式(I)代表的吲哚并[2-3-b]喹喔啉衍生物(其中 R¹ 和 R² 中的一个代表氢,另一个代表-CH₂NHCCH₃(CH₂OH)₂等;R³ 代表氢、甲基等)或其药学上可接受的盐具有抗肿瘤作用,因此可用作药物。